SGLT-话题@MedSci

#SGLT#

125篇内容 | 2803人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1793804, encodeId=b8e21e9380442, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响, objectType=article, longId=140961, objectId=878d1409614b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=878d1409614b, replyNumber=0, likeNumber=76, createdTime=2018-09-24, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=878d1409614b, moduleTitle=ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=878d1409614b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793813, encodeId=950d1e93813fd, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？, objectType=article, longId=149241, objectId=d458149241bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d458149241bb, replyNumber=0, likeNumber=100, createdTime=2018-12-21, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d458149241bb, moduleTitle=JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d458149241bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793810, encodeId=cdc51e9381020, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性, objectType=article, longId=147836, objectId=911e14e836f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=911e14e836f1, replyNumber=0, likeNumber=87, createdTime=2018-09-16, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=911e14e836f1, moduleTitle=FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=911e14e836f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793808, encodeId=a8711e9380824, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险, objectType=article, longId=146618, objectId=28f4146618a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f4146618a8, replyNumber=0, likeNumber=65, createdTime=2019-02-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f4146618a8, moduleTitle=JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28f4146618a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793803, encodeId=6e9a1e938035a, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, objectType=article, longId=139721, objectId=9b09139e213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b09139e213c, replyNumber=0, likeNumber=91, createdTime=2019-05-17, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b09139e213c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b09139e213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793800, encodeId=0ce41e93800bf, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, objectType=article, longId=130540, objectId=df9e130540b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df9e130540b9, replyNumber=0, likeNumber=112, createdTime=2018-12-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df9e130540b9, moduleTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df9e130540b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793798, encodeId=22f51e9379834, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹, objectType=article, longId=128540, objectId=2fed12854081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fed12854081, replyNumber=0, likeNumber=68, createdTime=2018-04-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fed12854081, moduleTitle=Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fed12854081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793805, encodeId=a61d1e9380590, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化, objectType=article, longId=141975, objectId=affd1419e50b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affd1419e50b, replyNumber=0, likeNumber=53, createdTime=2018-11-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affd1419e50b, moduleTitle=Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affd1419e50b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793806, encodeId=b79a1e93806ce, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？, objectType=article, longId=144604, objectId=dfa914460422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfa914460422, replyNumber=0, likeNumber=63, createdTime=2018-09-12, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfa914460422, moduleTitle=JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfa914460422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793795, encodeId=33fb1e93795bb, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, objectType=article, longId=124719, objectId=55c6124e19ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c6124e19ac, replyNumber=0, likeNumber=96, createdTime=2018-02-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c6124e19ac, moduleTitle=Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c6124e19ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793801, encodeId=31a81e93801b7, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, objectType=article, longId=131332, objectId=476e131332d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=476e131332d6, replyNumber=0, likeNumber=63, createdTime=2018-06-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=476e131332d6, moduleTitle=Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=476e131332d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793811, encodeId=65571e93811d8, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Obes Metab：SGLT-2i增加2型糖尿病患者酮症酸中毒风险？, objectType=article, longId=148362, objectId=f0c914836230, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0c914836230, replyNumber=0, likeNumber=114, createdTime=2019-08-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0c914836230, moduleTitle=Diabetes Obes Metab：SGLT-2i增加2型糖尿病患者酮症酸中毒风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0c914836230)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793794, encodeId=9ce61e937945c, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险, objectType=article, longId=117295, objectId=f03611e29509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03611e29509, replyNumber=0, likeNumber=56, createdTime=2018-08-30, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03611e29509, moduleTitle=Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03611e29509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793789, encodeId=5fa31e93789cf, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！, objectType=article, longId=110543, objectId=19a2110543e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a2110543e3, replyNumber=0, likeNumber=71, createdTime=2018-05-31, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a2110543e3, moduleTitle=Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a2110543e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793799, encodeId=e0ab1e93799a4, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂与下肢截肢风险！, objectType=article, longId=129835, objectId=b96412983500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b96412983500, replyNumber=0, likeNumber=62, createdTime=2018-02-23, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b96412983500, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂与下肢截肢风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b96412983500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793802, encodeId=35ee1e93802df, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=JACC：SGLT-2I能明显降低患者死亡和心衰发生风险, objectType=article, longId=139466, objectId=ec421394663b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec421394663b, replyNumber=0, likeNumber=69, createdTime=2018-10-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec421394663b, moduleTitle=JACC：SGLT-2I能明显降低患者死亡和心衰发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec421394663b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793796, encodeId=fbc61e93796b4, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？, objectType=article, longId=124757, objectId=8268124e577a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8268124e577a, replyNumber=0, likeNumber=75, createdTime=2018-01-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8268124e577a, moduleTitle=Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8268124e577a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793786, encodeId=265a1e9378679, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。, objectType=article, longId=102577, objectId=3a551025e7f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a551025e7f4, replyNumber=0, likeNumber=78, createdTime=2018-03-04, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a551025e7f4, moduleTitle=JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a551025e7f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793793, encodeId=8ea01e93793b0, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, objectType=article, longId=115490, objectId=c0a811549083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a811549083, replyNumber=0, likeNumber=80, createdTime=2018-04-08, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a811549083, moduleTitle=Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a811549083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793790, encodeId=d7c41e93790f0, content=<a href='/topic/show?id=5a3f1621e7d' target=_blank style='color:#2F92EE;'>#SGLT#</a>, objectTitle=Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多, objectType=article, longId=111182, objectId=d149111182b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d149111182b8, replyNumber=0, likeNumber=72, createdTime=2017-11-29, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d149111182b8, moduleTitle=Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d149111182b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SGLT

2020-05-29

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

ESH2018丨SGLT-2抑制剂对于合并糖尿病的高血压患者之影响

2018-09-24

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

JAMA Intern Med：SGLT-2抑制剂增加2型糖尿病患者截肢风险？

2018-12-21

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

FDA发出安全警告：2型糖尿病药物SGLT2抑制剂与严重的生殖器感染存在相关性

2018-09-16

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

JAMA Intern Med：SGLT-2抑制剂增加糖尿病患者下肢截肢风险

2019-02-06

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Obes Metab：SGLT-2抑制剂后来者居上长期疗效完胜DPP-4i和磺脲类

2019-05-17

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性

2018-12-09

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Obes Metab：治疗2型糖尿病 SGLT-2is或比DPP-4is更胜一筹

2018-04-09

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Sci rep：日本团队发现糖尿病治药 SGLT2 阻滞剂能延缓抑制非酒精脂肪肝炎及肝癌的发病及恶化

2018-11-18

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

JACC：SGLT-2抑制剂可否降低2型糖尿病患者的心血管事件风险？

2018-09-12

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Care：SGLT2抑制剂增加2型糖尿病患者急性肾损伤风险吗？

2018-02-20

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Obes Metab：T2DM患者进行DPP-4抑制与SGLT-2抑制对胰高血糖素的影响！

2018-06-18

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Obes Metab：SGLT-2i增加2型糖尿病患者酮症酸中毒风险？

2019-08-20

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetologia：SGLT2抑制剂致2型糖尿病患癌症的风险

2018-08-30

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Care：SGLT2抑制剂服用者发生急性肾损伤的风险分析！

2018-05-31

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Diabetes Obes Metab：SGLT-2抑制剂与下肢截肢风险！

2018-02-23

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

JACC：SGLT-2I能明显降低患者死亡和心衰发生风险

2018-10-20

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Circulation：SGLT2抑制剂能降低心衰患者的死亡率吗？

2018-01-08

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

JACC：在2型糖尿病老年患者中，钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂可降低心血管和心脏衰竭风险。

2018-03-04

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Lancet Diabetes Endo：2型糖尿病新用药者SGLT2抑制剂vs其他降糖药的心血管风险

2018-04-08

tulenzi (审核中...)

前往app查看评论内容

#SGLT#

Circulation：2型糖尿病患者初始SGLT-2抑制剂治疗获益良多

2017-11-29

科室
- - 订阅+
  - 更多科室
工具
服务